메뉴 건너뛰기




Volumn 59, Issue 4, 2002, Pages 372-377

Efficacy of HMG-CoA reductase inhibitors in treating osteoporosis

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; ALENDRONIC ACID; ANTILIPEMIC AGENT; ATORVASTATIN; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN 2; CALCITONIN; CALCIUM; CHOLESTEROL; COMPACTIN; CORTICOSTEROID; ESTROGEN; ESTROGEN RECEPTOR; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HEPARIN; HYDROXYAPATITE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; RALOXIFENE; RISEDRONIC ACID; SIMVASTATIN; VITAMIN D;

EID: 0037083330     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.4.372     Document Type: Note
Times cited : (4)

References (17)
  • 14
    • 0035901052 scopus 로고    scopus 로고
    • Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomized controlled trial
    • (2001) Lancet , vol.357 , pp. 509-512
    • Reid, I.R.1    Hague, W.2    Emberson, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.